Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Zastrozhin, Michael
21  Ergebnisse:
Personensuche X
?
1

Editorial: The utilization of bench-to-bedside approaches i..:

Rytkin, Eric ; Kriukova, Kseniia ; Denisenko, Natalia...
Frontiers in Pharmacology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

Olanzapine-Associated Rhabdomyolysis: A Case Report:

Skryabin, Valentin Y ; Zastrozhin, Michael ; Sychev, Dmitry A
Cureus.  , 2021
Link: https://doi.org/10.7759/..
 
?
3

A case of olanzapine-associated rhabdomyolysis:

Skryabin, Valentin ; Zastrozhin, Michael ; Sychev, Dmitry.
BJPsych Open.  7 (2021)  S1 - p. S53-S53 , 2021
Link: https://doi.org/10.1192/..
 
?
4

Influence of ABCB1 3435C>T polymorphism on methotrexate saf..:

Kubanov, Alexey A. ; Asoskova, Anastasiia V. ; Zastrozhin, Michael S...
Vestnik dermatologii i venerologii.  99 (2023)  1 - p. 18-26 , 2023
Link: https://doi.org/10.25208..
 
?
5

CYP2D6 gene polymorphic markers role in determining the opt..:

Sychev, Dmitry A. ; Parusov, Andrei I. ; Loranskaya, Irina D....
Terapevticheskii arkhiv.  94 (2022)  2 - p. 200-208 , 2022
Link: https://doi.org/10.26442..
 
?
6

The effect of brain neurotrophic factor gene polymorphism o..:

Poplevchenkov, Konstantin N. ; Agibalova, Tatyana V. ; Zastrozhin, Michael S..
Neurology Bulletin.  LIII (2021)  3 - p. 26-32 , 2021
Link: https://doi.org/10.17816..
 
?
7

Using a personalized clinical decision support system for b..:

Zastrozhin, Michael S. ; Sorokin, Aleksandr S. ; Agibalova, Tatyana V....
Human Psychopharmacology: Clinical and Experimental.  33 (2018)  6 - p. , 2018
Link: https://doi.org/10.1002/..
 
?
8

Pharmacodynamic genetic polymorphisms affect adverse drug r..:

Zastrozhin, Michael Sergeevich ; Brodyansky, Vadim ; Skryabin, Valentin...
Pharmacogenomics and Personalized Medicine.  10 (2017)  - p. 209-215 , 2017
Link: https://doi.org/10.2147/..
 
?
9

The correlation between CYP2D6 isoenzyme activity and halop..:

Sychev, Dmitry ; Zastrozhin, Michael Sergeevich ; Smirnov, Valery...
Pharmacogenomics and Personalized Medicine.  9 (2016)  - p. 89-95 , 2016
Link: https://doi.org/10.2147/..
 
?
10

SA106GENETICALLY DETERMINED GABA METABOLISM IS ASSOCIATED W..:

Bryleva, Anastasiia ; Ivashchenko, Dmitriy ; Solov'eva, Мaria...
European Neuropsychopharmacology.  29 (2019)  - p. S1246-S1247 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Editorial: The utilization of bench-to-bedside approaches i..:

Rytkin, Eric ; Kriukova, Kseniia ; Denisenko, Natalia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299726/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Pharmacodynamic genetic polymorphisms affect adverse drug r..:

Zastrozhin, Michael Sergeevich ; Brodyansky, Vadim ; Skryabin, Valentin...
info:eu-repo/semantics/altIdentifier/doi/10.2147/PGPM.S140700.  , 2017
Link: https://www.dovepress.co..
 
?
13

Editorial: The utilization of bench-to-bedside approaches i..:

Eric Rytkin ; Kseniia Kriukova ; Natalia Denisenko...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1234219/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
14

Influence of ABCB1 3435C>T polymorphism on methotrexate saf..:

Alexey A. Kubanov ; Anastasiia V. Asoskova ; Michael S. Zastrozhin..
https://vestnikdv.ru/jour/article/viewFile/1321/pdf.  , 2023
Link: https://doi.org/10.25208..
 
?
15

CYP2D6 gene polymorphic markers role in determining the opt..:

Dmitry A. Sychev ; Andrei I. Parusov ; Irina D. Loranskaya...
https://ter-arkhiv.ru/0040-3660/article/viewFile/105559/79974.  , 2022
Link: https://doi.org/10.26442..
 
1-15